Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | ESR1 | P03372 | 2/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.58 |
| ▸ | TACR2 | P21452 | 2/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | SHBG | P04278 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.58 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | TST | Q16762 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4532142 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4527877 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4203952 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL1301381 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4534627 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL974537 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL2733171 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4532942 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4528217 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL197275 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 652 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034124-A1 | NOVEL SALTS AND CRYSTALS | INTRA CELLULAR THERAPIES INC (US) | 2026-02-05 | — | — | US | claimed |
| EP-4561569-A2 | NOVEL SALTS AND CRYSTALS | Intra-Cellular Therapies, Inc. (US) | 2025-06-04 | — | — | EP | claimed |
| CN-113785243-B | Composition for resist pattern metallization process | 日产化学株式会社 | 2025-05-02 | — | — | CN | claimed |
| EP-3605097-B1 | SUBSTANCE THAT PREVENTS ANTIGEN-ANTIBODY REACTION INHIBITION BY BODY FLUID | NH FOODS LTD (JP) | 2024-11-13 | — | — | EP | claimed |
| US-12012540-B2 | Compositions and methods for selectively etching silicon nitride films | ENTEGRIS, INC. (US) | 2024-06-18 | — | — | US | claimed |
| US-20240131231-A1 | NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | NATIONAL INSTITUTES OF HEALTH | 2024-04-25 | — | — | US | claimed |
| EP-4347744-A1 | COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING SILICON NITRIDE FILMS | Entegris, Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| WO-2024030835-A2 | NOVEL SALTS AND CRYSTALS | INTRA-CELLULAR THERAPIES, INC. (US) | 2024-02-08 | — | — | WO | claimed |
| CN-117460805-A | Composition and method for selectively etching silicon nitride film | 恩特格里斯公司 | 2024-01-26 | — | — | CN | claimed |
| EP-4288123-A1 | NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | University of Georgia Research Foundation, Inc. (US) | 2023-12-13 | — | — | EP | claimed |
| EP-0554006-B1 | Polyunsaturated diazonium compounds | AGFA GEVAERT NV (BE) | 1999-04-28 | — | — | EP | claimed |
| WO-1998008919-A9 | NOVEL WATER SOLUBLE METAL WORKING FLUIDS | — | 1998-05-28 | — | — | WO | claimed |
| WO-1998008919-A2 | NOVEL WATER SOLUBLE METAL WORKING FLUIDS | SOLUTIA INC. (US) | 1998-03-05 | — | — | WO | claimed |
| EP-0825618-A2 | Electrically-conductive polymer and production method thereof, and solid-electrolytic capacitor | NEC CORPORATION (JP) | 1998-02-25 | — | — | EP | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| EP-0233072-B1 | IMPROVEMENTS IN OR RELATING TO RADIATION SENSITIVE MATERIAL | E.I. du Pont de Nemours and Company (US) | 1992-09-02 | — | — | EP | claimed |
| EP-0064338-B1 | COATING COMPOSITIONS CAPABLE OF CURING AT ROOM TEMPERATURE BASED ON A HYDROXYL GROUP-CONTAINING ADDITION POLYMER, AN ALKYLATED MELAMINE-FORMALDEHYDE CROSSLINKING AGENT AND A BLEND OF SPECIFIED ALKYLATED ARYLSULPHONIC ACIDS AS CATALYST | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-07-25 | — | — | EP | claimed |
| US-4452945-A | HYDROXYL GROUP CONTAINING ADDITION POLYMER AND ALKYLATED MELAMINE-FORMALDEHYDE CROSSLINKING AGENT | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-06-05 | — | — | US | claimed |
| EP-0064338-A1 | Coating compositions capable of curing at room temperature based on a hydroxyl group-containing addition polymer, an alkylated melamine-formaldehyde crosslinking agent and a blend of specified alkylated arylsulphonic acids as catalyst | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-11-10 | — | — | EP | claimed |
| US-4171459-A | Manufacture of α-naphthol | BASF AKTIENGESELLSCHAFT (DE) | 1979-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034124-A1 | NOVEL SALTS AND CRYSTALS | SLC6A4, SLC6A3, HTR2A | CA2 1503/4885ALDH1A1 1599/4885ESR1 649/4885 |
| US-20240131231-A1 | NITRIC OXIDE-RELEASING COMPOSITIONS AND APPLICATIONS THEREOF | NOS2, NOS1, NOS3 | CA2 3461/4885ALDH1A1 2686/4885ESR1 578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.